XML 70 R59.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Commitments and Contingencies - Narrative (Details)
1 Months Ended 3 Months Ended
May 01, 2024
D
$ / shares
Jan. 26, 2024
USD ($)
D
$ / shares
shares
Dec. 11, 2023
D
May 31, 2024
shares
Apr. 30, 2022
Mar. 31, 2024
USD ($)
May 16, 2024
$ / shares
Original Convertible promissory note              
Aggregate amount of notes issued | $   $ 2,250,000          
Interest rate percentage on the note   1.00%          
Maturity of issuance   1 year          
Debt instrument conversion price | $ / shares   $ 0.39109          
Volume weighted average price   110.00%          
Debt instrument trading days   7 7        
Debt instrument conversion of shares issued upon conversion (in shares) | shares   5,810,740          
Amended Convertible Promissory Note | Subsequent Events              
Debt instrument conversion price | $ / shares $ 0.39109           $ 0.11
Volume weighted average price 110.00%            
Debt instrument trading days 7            
Debt instrument conversion of shares issued upon conversion (in shares) | shares       20,781,771      
Amended Convertible Promissory Note | Scenario where company consummates a public financing within 60 days of May 1, 2024 | Subsequent Events              
Volume weighted average price 110.00%            
Debt instrument trading days 60            
Elusys Therapeutics              
Earn out payment period         12 years    
Percentage of earn out payments         10.00%    
Frequency of periodic earn out payment         1 year    
Period of occurrence of earn payment         9 years    
Future commitments | $           $ 51,400,000